87% of people don’t understand this rapidly growing market. Do you?
A win and loss for marijuana, a big advance in Alzheimer's disease, and the next big thing are among some of the market-moving things I expect to see happen this year.
Pfizer's stock is up 4% year-to-date, but this event was a clear disappointment for its shareholders in 2015.
One analyst thinks the iPad maker could be interested in acquiring Box or Adobe to build out its enterprise offering. Our analysts aren't convinced.
Want a bigger dividend payout? These three stocks may soon oblige such a request for income-seeking investors.
Learn how to identify solid dividend companies, and how to avoid being fooled by big yields.
This chip giant's next-generation processor could be just what Apple needs for a future Retina 5K iMac.
Tim Cook believes that iPad Pros will render PCs obsolete. Here are three simple reasons that argument doesn’t make sense.
Early human clinical trial results suggest that a better drug for lowering bad cholesterol may be on the horizon.
Intel's biggest buy yet could open up substantial opportunities, but it's not without significant risk as well.